Mindfulness-Based Social Cognition Training (SocialMind) for People With Psychosis: A Feasibility Trial

Conclusion: This is the first implementation of SocialMind, which is the first mindfulness-based social cognition training. It is well tolerated by participants with schizophrenia spectrum disorders, and a further randomized controlled trial is proposed for people who have suffered their first episode of psychosis within the past 5 years.Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03434405.IntroductionPeople suffering from psychosis frequently find it difficult to establish or maintain relationships with others or to engage in community activities (1, 2). These deficits are present even in high-risk or prodromal states (3), strengthening the role of social functioning as a core therapy outcome (4, 5). Social cognition is defined as “the psychological processes that are involved in the perception, encoding, storage, retrieval, and regulation of information of other people and ourselves” (6). It is associated with community functioning, with estimated average correlations ranging from 0.31 to 0.48 (7), and its deficits can also be observed in the early stages of the psychotic process (8).Antipsychotic medication improves positive and general psychiatric symptoms, but it has limited effect against negative syndrome, which consists of blunted affect, apathy, lack of spontaneity, and social withdrawal (9). These symptoms often respond to some psychological interventions, such as assertive community treatment, cognitive remediation, social skills ...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research

Related Links:

Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Source: Journal of Hazardous Materials - Category: Environmental Health Source Type: research
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part AAuthor(s): Zhongyi Zhang, Wen-Xiong Wang, Nengjian Zheng, Yansheng Cao, Hongwei Xiao, Renguo Zhu, Hui Guan, Huayun Xiao
Source: Journal of Hazardous Materials - Category: Environmental Health Source Type: research
Publication date: Available online 9 October 2020Source: Journal of Hazardous MaterialsAuthor(s): Yubo Cheng, Yiqiu Ma, Biao Dong, Xinghua Qiu, Di Hu
Source: Journal of Hazardous Materials - Category: Environmental Health Source Type: research
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
CONCLUSIONS: Immunohistochemistry seems to be a promising option not only in clinical recognition, but also in the selection and monitoring of treatment effects. However, these methods have not yet recommended for routine clinical use. PMID: 33032462 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
Publication date: Available online 9 October 2020Source: Cirugía Española (English Edition)Author(s): Victoria Lucas-Guerrero, Mireia Pascua-Solé, José Luis Ramos Rodríguez, Anna Trinidad Borrás, Carlos González de Pedro, José María Jover Navalón, Pere Rebasa, Eduardo M. Targarona Soler, Xavier Serra-Aracil, on behalf of the Comisión Nacional de la Especialidad de Cirugía General y del Aparato Digestivo, de la Sección de Formación de la Asociación Española de Cirujanos
Source: Cirugia Espanola - Category: Surgery Source Type: research
Source: European Journal of Sport Science - Category: Sports Medicine Authors: Source Type: research
Source: European Journal of Sport Science - Category: Sports Medicine Authors: Source Type: research
More News: Academia | Addiction | Anxiety | Behavioural Therapy | Brain | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | China Health | Chronic Pain | Clinical Trials | Cognitive Behavior Therapy | Depression | Disability | Education | Emergency Medicine | Environmental Health | Epidemiology | Generalized Anxiety Disorder (GAD) | Grants | Heart | Hong Kong Health | Learning | Legislation | Medical Ethics | Men | Neurology | Nicotine | Nursing | Nuts | Occupational Health | Pain | PET Scan | Psychiatry | Psychology | Psychotherapy | Reproduction Medicine | Schizophrenia | Spain Health | Statistics | Students | Study | Suicide | Teachers | Teaching | Training | UK Health | Universities & Medical Training